Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-07 · accession 0001439222-24-000142 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-12 | 2024-11-07+ | AGIO | Ballal Rahul D. | Dir | S - Sale+OE | $55.86 | -20.0K | 7,992 | -71% | -$1.12M |
| DM | 2024-11-12 | 2024-11-07+ | AGIO | Ballal Rahul D. | Dir | M - OptEx | $25.99 | +20.0K | 18.0K | New | +$519.8K |
| DM | 2024-11-12 | 2024-11-07+ | AGIO | Ballal Rahul D. | Dir | M - OptEx | $0.00 | -20.0K | 27.9K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-11-07 | S | D | 8,132 | $53.32 | 9,860 | D | — | — | (F2) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.00 to $53.84. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common stock | 2024-11-07 | M | A | 10,000 | $25.99 | 17,992 | D | — | — | |
| 3 | Common | Common stock | 2024-11-08 | M | A | 10,000 | $25.99 | 17,992 | D | — | — | |
| 4 | Common | Common stock | 2024-11-08 | S | D | 3,571 | $57.24 | 14,421 | D | — | — | (F4) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.00 to $58.00. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common stock | 2024-11-08 | S | D | 4,929 | $58.57 | 9,492 | D | — | — | (F5) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.00 to $58.99. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common stock | 2024-11-08 | S | D | 1,500 | $59.21 | 7,992 | D | — | — | (F6) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.01 to $59.37. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common stock | 2024-11-07 | S | D | 1,868 | $54.41 | 7,992 | D | — | — | (F3) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $54.02 to $54.60. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Derivative | Stock option (right to buy) | 2024-11-08 | M | D | 10,000 | $0.00 | 17,947 | D | $25.99 · — to 2032-08-11 | 10,000 Common stock | (F7) This option was granted on August 11, 2022. The shares underlying this option vest as to 25% of the underlying shares on August 11, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter. |
| 9 | Derivative | Stock option (right to buy) | 2024-11-07 | M | D | 10,000 | $0.00 | 27,947 | D | $25.99 · — to 2032-08-11 | 10,000 Common stock | (F7) This option was granted on August 11, 2022. The shares underlying this option vest as to 25% of the underlying shares on August 11, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter. |